Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures (Natalie Breymeyer/Axios)
Techmemeen

Natalie Breymeyer / Axios : Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures — Mithrl, an AI infrastructure company for biopharma, raised a $20 million Series A, CEO Vivek Adarsh tells Axios exclusively.
This is a short summary published by AI Global Wire. The full article is owned and hosted by Techmeme — open it there to read it in full.
Read the full story at TechmemeRelated AI news
- AI 雲端商 Nscale 挑戰赴美掛牌 高負債成 IPO 隱憂TechNews (TW) · September 21, 2026
- 甲骨文 AI 融資承壓 180 億美元貸款成燙手山芋TechNews (TW) · September 21, 2026
- Faraday Future says robotics, not EVs, must carry it to profitabilityDIGITIMES · September 21, 2026
- Acer founder says slowing AI development will be hard, amid call for AI slowdownDIGITIMES · September 21, 2026
- OpenAI 大舉擴編機器人團隊,祭 50 萬美元年薪強攻「實體 AI」版圖TechNews (TW) · September 21, 2026
- US says China talks yield progress on tariff carve-outs, AI dialogueNikkei Asia · September 21, 2026